Please login to the form below

Not currently logged in
Email:
Password:

GSK to build research centres in Shanghai

GSK has said it will spend USD 40m on the construction of a research facility in Shanghai which will eventually be one of its largest global research centres

According to local media reports, GlaxoSmithKline (GSK) will spend USD 40m (EUR 29.4m) on the construction of a research facility in Shanghai which will eventually be one of its largest global research centres.

GSK is looking for a research facility location in the city and aims to recruit 50 to 100 top international scientists.

Amy Huang, president of GSK operations on the Chinese mainland and Hong Kong, told state-owned press agency, China Daily, that China would not only be famous as the world's factory, but also attract global attention to its research and development for the pharmaceutical industry.

Other pharmaceutical majors include Novartis, which revealed back in November 2006 that it would build its eighth global research centre in China at an investment of USD 100m.

Three months ago, US pharmaceutical company Elli Lilly committed USD 100m (EUR 73.4m) for research in China. It also established a venture fund to invest in domestic drug developers, including a first investment of USD 10m (EUR 7.3m) in an unnamed local firm.

Perry Nisen, senior vice-president of clinical pharmacology and discovery medicine was reported as saying that the most important factor is access to scientific talent.

GSK had been investigating centres in India and South Korea, but finally selected Shanghai due to its number and quality of universities and hospitals and the density of foreign drug makers in the city, as well as its attraction to overseas scientists.

The GSK centre will be the only one for the company focusing on neurodegenerative disorders like Parkinson's disease, Alzheimer's disease and multiple sclerosis.

4th July 2007

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make...

Latest intelligence

segmentation_pie_thumb.jpg
If you’re not thinking segmentation, you’re not thinking
Having a background in market research I’ve been lucky to work on a number of customer segmentations in my time but working in creative communications it is still too rare...
Improving Outcomes in the Treatment of Opioid Dependence Highlights Report
The 16th annual ‘Improving Outcomes in the Treatment of Opioid Dependence’ (IOTOD)conference took place at the Hilton Madrid Airport hotel on 15–16 May 2018....
Londonvelophobia (fear of cycling in London) – debunked
...

Infographics